Topics

Fast track status given for Pulmatrix's asthma drug

06:41 EST 31 Jan 2020 | SmartBrief

Pulmatrix's inhalable formulation of its investigational treatment itraconazole for allergic bronchopulmonary aspergillosis i -More

Original Article: Fast track status given for Pulmatrix's asthma drug

NEXT ARTICLE

More From BioPortfolio on "Fast track status given for Pulmatrix's asthma drug"

Quick Search